Neurobiology of Aging
Volume 29, Issue 8 , Pages 1160-1166 , August 2008

Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease

  • María J. Bullido

      Affiliations

    • Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
    • ,
  • Ana Martínez-García

      Affiliations

    • Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
    • These two authors contributed equally to this work.
    • ,
  • Raquel Tenorio

      Affiliations

    • Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
    • These two authors contributed equally to this work.
    • ,
  • Isabel Sastre

      Affiliations

    • Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
    • ,
  • David G. Muñoz

      Affiliations

    • University of Toronto & St. Michael's Hospital, Toronto, Canada
    • ,
  • Ana Frank

      Affiliations

    • Servicio de Neurología, Hospital Universitario La Paz (UAM), 28034 Madrid, Spain
    • ,
  • Fernando Valdivieso

      Affiliations

    • Departamento de Biología Molecular and Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 91 497 84 71; fax: +34 91 497 48 70.

Received 26 October 2006 ,Revised 9 February 2007 ,Accepted 15 February 2007.

References 

  1. Anon., 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 (4 Suppl.), S1–S2.
  2. Bauer D, Tampe R. Herpes viral proteins blocking the transporter associated with antigen processing TAP—from genes to function and structure. Curr. Top. Microbiol. Immunol. 2002;269:87–99
  3. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J. Clin. Invest. 2005;115(6):1449–1457
  4. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 1998;18(1):69–71
  5. Bullido MJ, Martinez-Garcia A, Artiga MJ, Aldudo J, Sastre I, Gil P, et al. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. Neurobiol. Aging. 2007;28(4):519–523
  6. Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J. Virol. 2002;76(23):12394–12398
  7. Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport. 2003;14(14):1825–1827
  8. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 2002;3(4):285–298
  9. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31(13):3568–3571
  10. Conde L, Vaquerizas JM, Santoyo J, Al-Shahrour F, Ruiz-Llorente S, Robledo M, et al. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res. 2004;32(Web Server issue):W242–W248
  11. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–923
  12. Chang RC, Wong AK, Ng HK, Hugon J. Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport. 2002;13(18):2429–2432
  13. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15(5):365–375
  14. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006;70(4):1032–1060
  15. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 2006;13(3):393–403
  16. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997;349(9047):241–244
  17. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Prog. Lipid Res. 2006;45(1):73–90
  18. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 2003;4(6):411–419
  19. Lambert JC, Goumidi L, Vrieze FW, Frigard B, Harris JM, Cummings A, et al. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum. Mol. Genet. 2000;9(15):2275–2280
  20. Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. U.S.A. 2006;103(26):10005–10010
  21. McCluskey J, Rossjohn J, Purcell AW. TAP genes and immunity. Curr. Opin. Immunol. 2004;16(5):651–659
  22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–944
  23. Mohr I. Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int. Rev. Immunol. 2004;23(1–2):199–220
  24. Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, Baba T, et al. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 2004;23(4):959–968
  25. Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38(3–4):409–415
  26. Peel AL. PKR activation in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 2004;63(2):97–105
  27. Peel AL, Bredesen DE. Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 2003;14(1):52–62
  28. Wilson HS, Skodol A. Special report: DSM-IV: overview and examination of major changes. Arch. Psychiatr. Nurs. 1994;8(6):340–347

PII: S0197-4580(07)00081-4

doi: 10.1016/j.neurobiolaging.2007.02.023

Neurobiology of Aging
Volume 29, Issue 8 , Pages 1160-1166 , August 2008

Article Tools

* Image Usage & Resolution